Eastgate Biotech Corp. (ETBI) 0.0130 $ETBI
EastGate Biotech Announces That Its Research Collaborator, the University of Guelph, Department of Molecular and Cellular Biology Receives NSERC Grant
Marketwired - Tue Jul 07, 8:30AM CDT
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced that its research collaborator, the University of Guelph, Department of Molecular and Cellular Biology received a grant from the National Sciences and Engineering Research Council of Canada (NSERC). The grant was approved for the development and evaluation of new nano delivery vehicles for natural antimicrobial products with improved efficacy..
EastGate Biotech Announces That Impex Healthcare Will Distribute One of Its Products, Glucora
Marketwired - Tue Jun 09, 8:30AM CDT
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced that Impex Healthcare (www.ImpexHealthcare.com) will commence the distribution and marketing of one of the company's natural products, Glucora, in Bangladesh along with future distribution of other glucose management products.
EastGate Biotech Announces Collaboration With the University of Guelph, Department of Molecular and Cellular Biology, for Its Natural Antibacterial Products
Marketwired - Thu May 28, 8:30AM CDT
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced today its collaboration with the University of Guelph, Department of Molecular and Cellular Biology. The collaboration involves evaluation of the antimicrobial activity of the company's natural antibacterial products, Cleanezze(TM) and VClean(TM).
EastGate Biotech Announces That PharmaCenter Ltd. Will Commence Marketing the Company's Nutraceutical Products
Marketwired - Tue May 26, 10:15AM CDT
EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced that PharmaCenter (www.PharmaCenter.sk or www.PharmaCenter.hu) will commence marketing E-drops, one of the company's nutraceutical products in Slovakia and Czech Republic.
EastGate Biotech Receives Purchase Order from its Canadian Distributor for Nutraceutical Products
PR Newswire - Wed Mar 11, 8:30AM CDT
EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules has received a purchase order from its newly-engaged Canadian distributor Preferred Nutrition (www.pno.ca). The company has already received a cash deposit for this initial order.
EastGate Biotech Provides Update On Its Patent Portfolio
PR Newswire - Tue Feb 03, 8:30AM CST
EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules provides update on its patent portfolio for its sub-micron self-nanoemulsifying platform technology.
EastGate Biotech Corp. Receives An NPN (Natural Product Number) For Its Product Glucora, Designed To Support Healthy Glucose Metabolism
PR Newswire - Fri Jan 23, 8:30AM CST
EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules receives an NPN (Natural Product Number) from the Natural and Non-Prescription Health Products Directorate of Health Canada for its natural product Glucora.
EastGate Biotech Corp. Names New President
PR Newswire - Tue Jan 20, 8:30AM CST
EastGate Biotech Corp., formerly EastGate Acquisitions Corporation (OTCBB: ETBI), an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules has appointed Rose C. Perri as President. Ms. Perri was previously engaged in Business Development activities at EastGate Biotech. She replaces Mirjana Hasanagic who has resigned as President and who will now serve as the Vice President, Natural Products. Ms. Hasanagic will remain as a Director of EastGate's Board of Directors.
EastGate Acquisitions Announces Name Change To EastGate Biotech Corp. And New Stock Symbol
PR Newswire - Mon Dec 15, 8:30AM CST
EastGate Biotech Corp., formerly EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules, announced today that the Financial Industry Regulatory Authority ("FINRA"
approved the company's change of corporate name to EastGate Biotech Corp. from EastGate Acquisitions Corporation . The Company's new trading symbol "ETBI" is now effective.
EastGate Biotech Announces That Its Research Collaborator, the University of Guelph, Department of Molecular and Cellular Biology Receives NSERC Grant
Marketwired - Tue Jul 07, 8:30AM CDT
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced that its research collaborator, the University of Guelph, Department of Molecular and Cellular Biology received a grant from the National Sciences and Engineering Research Council of Canada (NSERC). The grant was approved for the development and evaluation of new nano delivery vehicles for natural antimicrobial products with improved efficacy..
EastGate Biotech Announces That Impex Healthcare Will Distribute One of Its Products, Glucora
Marketwired - Tue Jun 09, 8:30AM CDT
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced that Impex Healthcare (www.ImpexHealthcare.com) will commence the distribution and marketing of one of the company's natural products, Glucora, in Bangladesh along with future distribution of other glucose management products.
EastGate Biotech Announces Collaboration With the University of Guelph, Department of Molecular and Cellular Biology, for Its Natural Antibacterial Products
Marketwired - Thu May 28, 8:30AM CDT
EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced today its collaboration with the University of Guelph, Department of Molecular and Cellular Biology. The collaboration involves evaluation of the antimicrobial activity of the company's natural antibacterial products, Cleanezze(TM) and VClean(TM).
EastGate Biotech Announces That PharmaCenter Ltd. Will Commence Marketing the Company's Nutraceutical Products
Marketwired - Tue May 26, 10:15AM CDT
EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced that PharmaCenter (www.PharmaCenter.sk or www.PharmaCenter.hu) will commence marketing E-drops, one of the company's nutraceutical products in Slovakia and Czech Republic.
EastGate Biotech Receives Purchase Order from its Canadian Distributor for Nutraceutical Products
PR Newswire - Wed Mar 11, 8:30AM CDT
EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules has received a purchase order from its newly-engaged Canadian distributor Preferred Nutrition (www.pno.ca). The company has already received a cash deposit for this initial order.
EastGate Biotech Provides Update On Its Patent Portfolio
PR Newswire - Tue Feb 03, 8:30AM CST
EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules provides update on its patent portfolio for its sub-micron self-nanoemulsifying platform technology.
EastGate Biotech Corp. Receives An NPN (Natural Product Number) For Its Product Glucora, Designed To Support Healthy Glucose Metabolism
PR Newswire - Fri Jan 23, 8:30AM CST
EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules receives an NPN (Natural Product Number) from the Natural and Non-Prescription Health Products Directorate of Health Canada for its natural product Glucora.
EastGate Biotech Corp. Names New President
PR Newswire - Tue Jan 20, 8:30AM CST
EastGate Biotech Corp., formerly EastGate Acquisitions Corporation (OTCBB: ETBI), an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules has appointed Rose C. Perri as President. Ms. Perri was previously engaged in Business Development activities at EastGate Biotech. She replaces Mirjana Hasanagic who has resigned as President and who will now serve as the Vice President, Natural Products. Ms. Hasanagic will remain as a Director of EastGate's Board of Directors.
EastGate Acquisitions Announces Name Change To EastGate Biotech Corp. And New Stock Symbol
PR Newswire - Mon Dec 15, 8:30AM CST
EastGate Biotech Corp., formerly EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules, announced today that the Financial Industry Regulatory Authority ("FINRA"
approved the company's change of corporate name to EastGate Biotech Corp. from EastGate Acquisitions Corporation . The Company's new trading symbol "ETBI" is now effective. 
